1. Home
  2. KFII vs LAB Comparison

KFII vs LAB Comparison

Compare KFII & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KFII
  • LAB
  • Stock Information
  • Founded
  • KFII 2024
  • LAB 1999
  • Country
  • KFII United States
  • LAB United States
  • Employees
  • KFII N/A
  • LAB N/A
  • Industry
  • KFII
  • LAB Biotechnology: Laboratory Analytical Instruments
  • Sector
  • KFII
  • LAB Industrials
  • Exchange
  • KFII NYSE
  • LAB Nasdaq
  • Market Cap
  • KFII 393.3M
  • LAB 372.1M
  • IPO Year
  • KFII 2025
  • LAB 2011
  • Fundamental
  • Price
  • KFII $10.18
  • LAB $1.34
  • Analyst Decision
  • KFII
  • LAB Buy
  • Analyst Count
  • KFII 0
  • LAB 2
  • Target Price
  • KFII N/A
  • LAB $2.50
  • AVG Volume (30 Days)
  • KFII 89.7K
  • LAB 2.8M
  • Earning Date
  • KFII 01-01-0001
  • LAB 07-30-2025
  • Dividend Yield
  • KFII N/A
  • LAB N/A
  • EPS Growth
  • KFII N/A
  • LAB N/A
  • EPS
  • KFII N/A
  • LAB N/A
  • Revenue
  • KFII N/A
  • LAB $169,687,000.00
  • Revenue This Year
  • KFII N/A
  • LAB N/A
  • Revenue Next Year
  • KFII N/A
  • LAB $12.18
  • P/E Ratio
  • KFII N/A
  • LAB N/A
  • Revenue Growth
  • KFII N/A
  • LAB 33.86
  • 52 Week Low
  • KFII $9.90
  • LAB $0.92
  • 52 Week High
  • KFII $10.20
  • LAB $2.41
  • Technical
  • Relative Strength Index (RSI)
  • KFII N/A
  • LAB 58.76
  • Support Level
  • KFII N/A
  • LAB $1.27
  • Resistance Level
  • KFII N/A
  • LAB $1.41
  • Average True Range (ATR)
  • KFII 0.00
  • LAB 0.11
  • MACD
  • KFII 0.00
  • LAB 0.01
  • Stochastic Oscillator
  • KFII 0.00
  • LAB 50.00

About KFII K&F GROWTH ACQUISITION CORP II

K&F Growth Acquisition Corp II is a special purpose acquisition company.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: